Brainsway Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Brainsway Ltd., a foreign private issuer, on February 19, 2026. The filing serves to disclose a material corporate event rather than a standard periodic financial report.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is an event-driven disclosure and does not contain financial statements.
Material Changes
The primary material change disclosed is a new minority-stake investment by Brainsway Ltd. in BrainStim Health Inc., a Canadian provider. Details regarding the investment amount, ownership percentage, and strategic rationale are referenced in Exhibit 99.1 but are not detailed in the cover text of this filing.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future performance, or a discussion of risks and contingencies beyond the announcement of the investment. The document incorporates by reference into prior Registration Statements on Forms S-8 and F-3.
Investor Verification Checklist
- Review Exhibit 99.1 for the specific terms, valuation, and ownership percentage of the investment in BrainStim Health Inc.
- Verify the strategic fit of the Canadian provider with Brainsway's existing neuromodulation portfolio.
- Check subsequent filings for any financial impact of this investment on Brainsway's balance sheet or cash flow.
- Confirm if this investment triggers any regulatory filings in Canada or Israel.